Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Feb 7, 2022
Date Accepted: Jun 13, 2022
Mobile applications for people with rare diseases: A review and quality assessment using MARS
ABSTRACT
Background:
The low prevalence of rare diseases means high-quality evidence and guidelines concerning what is best practice is often unclear. The internet has assisted with this problem as electronic resources such as websites or interactive mobile applications designed for smartphones and tablets have become available. Such resources can provide web-based information, helplines, social support, and condition management support for people with a rare disease, their families, or both. The extent of the needs of this group, the electronic resources available, and how such resources may help address these needs is poorly understood.
Objective:
The aim of this scoping review is to assess the range and nature of a subset of electronic resources (apps) developed specifically for people diagnosed with a rare disease.
Methods:
Google Playstore (Android) and Apple AppStore (iOS) were searched for relevant health related apps specifically for rare diseases. Searches were run using the Google incognito mode to lessen the influence of searchers’ browser history. The search included the names of ten rare diseases. Rare diseases were defined as having an incidence of <1:2000. App quality was determined using the Mobile App Rating Scale (MARS) assessing app engagement, functionality, aesthetics and information.
Results:
We found 29 relevant apps (from 2,272) addressing 13 rare diseases/disease groups. Most common rare conditions addressed were cystic fibrosis and haemophilia. Most common features of the apps were online information and symptom trackers. On a 5-point scale, MARS scores ranged between 1.95 to 4.69.
Conclusions:
Most apps focused on providing factual and visual information, providing tools for self-management practices and resources to help improve interactions during health consultations. App origin and quality varied greatly. Apps that scored highest on MARS were co-designed by patients, clinicians, researchers and developers. Clinical Trial: N/A
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.